Citigroup Inc. lowered its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 0.9% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 17,634 shares of the company’s stock after selling 157 shares during the quarter. Citigroup Inc.’s holdings in HealthEquity were worth $878,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the company. GSA Capital Partners LLP grew its holdings in shares of HealthEquity by 355.4% during the 2nd quarter. GSA Capital Partners LLP now owns 30,265 shares of the company’s stock worth $1,508,000 after purchasing an additional 23,619 shares during the period. UBS Asset Management Americas Inc. grew its holdings in shares of HealthEquity by 24.3% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 28,342 shares of the company’s stock worth $1,412,000 after purchasing an additional 5,544 shares during the period. Nicholas Investment Partners LP grew its holdings in shares of HealthEquity by 11.2% during the 2nd quarter. Nicholas Investment Partners LP now owns 137,171 shares of the company’s stock worth $6,837,000 after purchasing an additional 13,848 shares during the period. Rafferty Asset Management LLC purchased a new stake in shares of HealthEquity during the 2nd quarter worth about $848,000. Finally, New York State Common Retirement Fund grew its holdings in shares of HealthEquity by 5.0% during the 2nd quarter. New York State Common Retirement Fund now owns 159,277 shares of the company’s stock worth $7,937,000 after purchasing an additional 7,622 shares during the period. Institutional investors and hedge funds own 90.97% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/citigroup-inc-decreases-stake-in-healthequity-inc-hqy/1617118.html.

HealthEquity, Inc. (HQY) opened at 51.91 on Friday. The stock has a market cap of $3.14 billion, a PE ratio of 77.02 and a beta of 1.80. HealthEquity, Inc. has a 12-month low of $30.34 and a 12-month high of $54.95. The firm has a 50-day moving average price of $45.91 and a 200-day moving average price of $46.52.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, September 5th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.14 by $0.13. The firm had revenue of $56.90 million for the quarter, compared to analyst estimates of $55.66 million. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The company’s revenue was up 28.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.16 EPS. Analysts forecast that HealthEquity, Inc. will post $0.71 EPS for the current fiscal year.

In other HealthEquity news, VP Darcy G. Mott sold 9,500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 20th. The stock was sold at an average price of $46.79, for a total value of $444,505.00. Following the sale, the vice president now owns 87,500 shares of the company’s stock, valued at approximately $4,094,125. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Stephen Neeleman sold 8,500 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $45.24, for a total value of $384,540.00. Following the completion of the sale, the insider now directly owns 1,000 shares in the company, valued at approximately $45,240. The disclosure for this sale can be found here. Insiders sold a total of 1,153,704 shares of company stock worth $58,570,360 in the last ninety days. Insiders own 29.00% of the company’s stock.

A number of equities analysts have weighed in on the company. TheStreet upgraded HealthEquity from a “c” rating to a “b” rating in a report on Monday, July 31st. Zacks Investment Research cut HealthEquity from a “buy” rating to a “hold” rating in a report on Friday, August 4th. BidaskClub upgraded HealthEquity from a “strong sell” rating to a “sell” rating in a report on Friday, September 15th. Cantor Fitzgerald restated a “buy” rating and issued a $56.00 price target on shares of HealthEquity in a report on Tuesday, August 29th. Finally, Robert W. Baird restated a “hold” rating on shares of HealthEquity in a report on Thursday, September 21st. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $56.50.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.